What Happened? Shares of health insurance company Humana (NYSE:HUM) fell 15.3% in the pre-market session after peer ...

Humana Inc. HUM remains well-poised for growth on the back of improved premium revenues, an aging U.S. population, acquisitions and adequate cash generation abilities. A strong 2025 outlook reinforces ...

Still, year-over-year growth in the Medicare ... MA insurers promised to shed members to resuscitate flagging margins last year. Worse benefits and fewer plans available is one explanation for ...

Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.

Payers offered fewer MA plans than they had in the previous year. The total number of MA plans available grew from 4,284 in 2020 to 5,673 in 2024 before falling to 5,581 in 2025. Additionally, more ...

Humana Inc. HUM remains well-poised for growth on the back of improved premium revenues, an aging U.S. population, acquisitions and adequate cash generation abilities. A strong 2025 outlook ...